-
The Most Valuable Unsold Assets of the Pharmaceutical Industry in 2017
en-cphi.cn
September 08, 2017
According to data of EvaluatePharma, the top 2 on the following list are Kite Pharma’s CAR-T therapy and Incyte’s IDO inhibitor, and DBV’s peanut allergy vaccine and Karyopharm’s cancer treatment selinexor also rank in the top 15.
-
Achievements of 5 Transnational Pharmaceutical Enterprises in China!
en-CPhI.cn
August 28, 2017
Greeting Key Nodes in the Transition in China, High-speed Growth being a Normal
-
NSF International provides pharma biotech services from India office
expressbpd
August 08, 2017
Consulting and technical services are being provided due to growing demand from Indian pharma industry
-
New research highlights lack of confidence in serialization preparations
cphi-online
July 27, 2017
40% of industry professionals admit they are not clear about the global requirements for serialization.
-
Orphan drugs become the new favorite of pharmaceutical industry upon the huge market potential
en-cphi.cn
April 07, 2017
FDA approved the marketing application of Merck Serono’s Avelumab through accelerated approval on March 23, 2017, which can be said to ignite the medical circle and again draws the public interest in words like “orphan drug” and “rare disease”.
-
Pharmaceutical Industry Outlook 2030 at the Crossroads: From Evolution to Revolution (2)
en-cphi.cn
March 23, 2017
An increasing number of pharmaceutical companies and medical device companies are cooperating and integrating with technology enterprises.
-
Pharmaceutical Industry Outlook 2030 at the Crossroads: From Evolution to Revolution (1)
en-cphi.cn
March 23, 2017
The Pharma outlook 2030: From evolution to revolution recently issued by KPMG points out that the pharmaceutical industry is at a crossroads.